Stocks
ZYNEX INCZYXIQ
HealthcareDiagnostics
A developer of molecular diagnostic products, primarily for infectious disease testing, with a focus on respiratory panels and antimicrobial stewardship. The company's FDA-cleared and CE-marked assays target pathogens like SARS-CoV-2, influenza, and RSV, and it has carved out a niche in syndromic testing for urgent care and hospital settings. Investors track Zynex for its revenue growth trajectory and its ability to expand its menu of tests in a competitive molecular diagnostics market.
Congressional Interest in ZYNEX INC (ZYXIQ)
No congressional trades have been disclosed for ZYNEX INC (ZYXIQ) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading ZYXIQ?
No congressional trades found for this stock.